FDA.reportPublic FDA data

NDC 50090-6089-01 - Levothyroxine sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50090-6089
Requested NDC
50090-6089-01
Package NDCs from labels
50090-6089-0, 50090-6089-1, 50090-6089-01
Manufacturer
A-S Medication Solutions
Effective date
2025-07-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Levothyroxine sodium - A-S Medication SolutionsA-S Medication Solutions2025-07-15HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-6089-0Levothyroxine sodium90 in 1 BOTTLETABLET905
50090-6089-1Levothyroxine sodium30 in 1 BOTTLETABLET305

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-6089LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS]3Current NDC, Legacy NDC, 2 package rows20230602_70d84fe0-afc4-4ef2-b4d8-f156abac3d1f.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-6089-0EA - Each50090-60891b7b2683-840d-46d0-917e-a7d77279de7012022-10-06
50090-6089-1EA - Each50090-6089bbb03dd6-2ec1-454d-b7e9-edf6bd5c9c2f12022-10-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 18 · 346 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions67f46137-afc4-471b-a6c7-9c2aef92da5d2026-03-03Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 892251
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMPD-Rx Pharmaceuticals, Inc.70a9bb5c-2259-405e-8d89-cc1db8c707432026-02-25Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 966221
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMPD-Rx Pharmaceuticals, Inc.6f4998ac-0714-4f5d-8944-9e6902b9f0a62026-02-25Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 892246
unii: 9J765S329G
FolartexMULTIVITAMINOncora Pharma, LLC0a4cb0ab-565f-45e8-a989-740bccef21cd2026-02-25Warnings, Adverse reactionsExact identifier
unii: 3A3U0GI71G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions853d9e86-2b5b-4967-8c22-70ad34f034182026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966220
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutionsb42fe9dd-8383-4839-9eab-393de388da712026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966220
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutionsfa7dd488-de7e-4f9e-87db-18391b723aad2026-02-19Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 966270
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions394b1006-c160-4668-8684-82d1c44812022026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966253
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions8e11401b-f5c2-42ac-ba63-2e71b5626b7e2026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966253
unii: 9J765S329G
AfloraMULTIVITAMINOncora Pharma, LLC38e463d1-f608-7cb5-e063-6294a90a4abb2026-02-12Warnings, Adverse reactionsExact identifier
unii: 3A3U0GI71G
FolixiaMULTIVITAMINOncora Pharma, LLC413945b5-116b-d8b6-e063-6394a90a55e82026-02-12Warnings, Adverse reactionsExact identifier
unii: 3A3U0GI71G
NutralynMULTIVITAMINOncora Pharma, LLC33da017b-1e8c-d41c-e063-6394a90aab8c2026-02-12Warnings, Adverse reactionsExact identifier
unii: 3A3U0GI71G
FolatenMULTIVITAMINOncora Pharma, LLC93086235-2c33-424d-b0c3-2130319885812026-02-12Warnings, Adverse reactionsExact identifier
unii: 3A3U0GI71G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions4520fae0-acce-47a0-af9e-f4f16ea6b2682026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 892246
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMA-S Medication Solutions2ce47caf-6ece-429c-b5d7-c47ba69528002026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 892246
unii: 9J765S329G
Levothyroxine SodiumLEVOTHYROXINE SODIUMA-S Medication Solutions99df68ea-4de7-4825-a6d7-894c70d01c282026-02-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966222
unii: 9J765S329G
Levothyroxine SodiumLEVOTHYROXINE SODIUMA-S Medication Solutions4f26f9dc-cf49-4b55-a6f7-f2f579893ee42026-02-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966222
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions2b737395-0238-400b-95ff-890b95c984252026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966224
unii: 9J765S329G
Levothyroxine sodiumLEVOTHYROXINE SODIUMASCLEMED USA INC.42a26f8a-dc67-42e4-abb0-d2602afb1b7d2026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA212399
rxcui: 966248
rxcui: 892251
rxcui: 966222
rxcui: 966270
rxcui: 892246
rxcui: 966221
rxcui: 892255
rxcui: 966224
rxcui: 966249
rxcui: 966220
rxcui: 966225
rxcui: 966253
unii: 9J765S329G
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions1ac29774-2b53-4a3f-97fa-16c2880a08682026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966224
unii: 9J765S329G

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.